CMU Student Develops Innovative Protein for Diabetes Management

A student from Central Michigan University (CMU) is making significant strides in diabetes management through the development of a novel protein aimed at regulating blood sugar levels. Brevin St. Onge, a neuroscience student from Mt. Pleasant, has dedicated over a year to creating a prototype protein that detects elevated glucose levels in the bloodstream and aids cells in utilizing that sugar without relying on insulin.

The innovative protein binds to glucose when present, effectively mimicking the functions typically triggered by insulin. Additionally, it emits light in response to glucose; the intensity of the light corresponds to the concentration of sugar in the blood, providing a real-time monitoring system. This advancement has the potential to offer patients a less invasive method for tracking their condition, thereby reducing the risk of long-term complications associated with poorly controlled blood sugar levels, including dementia and Alzheimer’s disease.

St. Onge expressed optimism about the protein’s impact, stating, “What difference will this make for people who suffer from diabetes or insulin resistance? Well, it will be astronomical to be completely honest with you. You’ll be less susceptible to contracting one of those neurodegenerative diseases in the future or type 1 diabetes or insufficiency in that aspect.”

The research conducted by St. Onge has garnered attention and support, as it played a crucial role in CMU receiving a grant of $75,000 to further advance this project. Another student has already committed to continuing the research alongside Dr. Eric Peterson, ensuring that the work will progress despite St. Onge’s impending application to medical school.

The implications of this research extend beyond individual health management. By potentially revolutionizing the way patients monitor their blood sugar levels, this protein could represent a significant leap forward in diabetes care. As the project develops, it may pave the way for innovative treatments that enhance the quality of life for millions affected by diabetes worldwide.